EichorEICHOR
Location: Hebei Synced from ClinicalTrials.gov · August 09, 2026

Clinical studies recruiting near Hebei

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre
Phase 3 · Tasly Pharmaceutical Group Co., Ltd · NCT07687186
This Study is a FIH Study Which is Required to Understand the PK Characteristics, MTD, RP2D and Safety Profile.
Phase 1 · Nanjing RegeneCore Biotech Co., Ltd. · NCT06756451
Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Capecitabine in the Treatment of Advanced Triple-negative Bre
Phase 2 · Hebei Medical University Fourth Hospital · NCT04159142
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · Bristol-Myers Squibb · NCT06929273
Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Mod
Phase 3 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06682169
A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis
Phase 1/Phase 2 · Chipscreen Biosciences, Ltd. · NCT07129382
A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease
Phase 2 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06300320
A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer
Phase 1/Phase 2 · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT06431490
Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke
Phase 2 · Kunming Pharmaceuticals, Inc. · NCT07279493
A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multi
Phase 1 · Shanghai Henlius Biotech · NCT07160335
The Chinese Familial Alzheimer's Network
Phase N/A · Capital Medical University · NCT03657732
Mobile Applet for Weight Management in Obese Heart Failure Patients
NA · Heart Health Research Center · NCT06455878
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Amgen · NCT07037433
A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia
Phase 3 · Hasten Biopharmaceutical Co., Ltd. · NCT06568471
Radiotherapy + Systemic Therapy as Conversion Therapy for pMMR/MSS T4M0 Colon Cancer(Neo-Color)
Phase 2 · Hebei Medical University Fourth Hospital · NCT06949111
A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopa
Phase N/A · Bristol-Myers Squibb · NCT07361289
Comparison of the Pharmacokinetics (PK)and Pharmacodynamics (PD)Biosimilarity of Insulin Aspart Injections After Single-
NA · Zhuhai United Laboratories Co., Ltd. · NCT07600944
Robot-Assisted vs Manual Transradial Cerebral Angiography
NA · The First Hospital of Hebei Medical University · NCT07696936
Clinical Trials of Quadrivalent Influenza Vaccine
Phase 1/Phase 2 · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · NCT06824519
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathie
Phase 3 · Pfizer · NCT05895786
A Study of Comparing Overall Improvement of Patients With Spondyloarthritis Treated With Jitongning Tablets and Placebo
Phase 3 · Tasly Pharmaceutical Group Co., Ltd · NCT06000956
A Study to Evaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectabl
Phase 2 · Innovent Biologics (Suzhou) Co. Ltd. · NCT06797297
Clinical Multimodal Surveillance of Respiratory Syndrome Pathogens
Phase N/A · Huashan Hospital · NCT07694648
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Phase 3 · Celgene · NCT05519085
A Trial of SHR-A1811 Combined With Other Antitumor Therapies in Advanced Solid Tumors.
Phase 1/Phase 2 · Jiangsu HengRui Medicine Co., Ltd. · NCT06015048
A Study of JAB-21822 in Advanced or Metastatic NSCLC With KRAS p.G12C and STK11 Co-mutation and Wild-type KEAP1
Phase 1/Phase 2 · Allist Pharmaceuticals, Inc. · NCT05276726
Chinese Psoriasis Real World Evidence Research
Phase N/A · the First Hospital of Hebei Medical University · Second Affiliated Hospital, Zhejiang University, School of M · NCT04465838
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Phase N/A · AstraZeneca · NCT06465810
Advancing Reperfusion Therapy for Ischemic Stroke: Perfusion-guided Endovascular Intervention for Medium Vessel Occlusio
NA · Beijing Tiantan Hospital · NCT07323368
China HeadAche DIsorders RegiStry
Phase N/A · Beijing Tiantan Hospital · NCT05334927
Look up another city
Look up another condition